9258 Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-722
Closed -$214K – 279
2019
Q4
$214K Buy
+722
New +$200K 0.08% 269
2019
Q1
– Sell
-780
Closed -$235K – 178
2018
Q4
$235K Buy
+780
New +$249K 0.23% 137

Other funds holding BIIB

9258 Wealth Management's BIIB Position: Q1 2020 in Review

9258 Wealth Management sold out of Biogen (BIIB) in Q1 2020, closing a stake of 722 shares — an estimated $214K sold.

9258 Wealth Management first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $235K in Q4 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q1 2020.

  • 9258 Wealth Management reported no remaining Biogen position as of Q1 2020 after selling out during the quarter.
  • 9258 Wealth Management sold 722 Biogen shares in Q1 2020, an estimated $214K.
  • 9258 Wealth Management first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
  • 9258 Wealth Management's Biogen position peaked at $235K in Q4 2018.
  • 1,098 funds tracked by Wall St. Rank held Biogen as of Q1 2020.

Based on 9258 Wealth Management's 13F filing for Q1 2020, filed 5 May 2020.